Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 53501-53550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05870267
Biomechanical Assessment of Load Applied on Residuum of Individuals With Limb Loss Fitted With a Prosthetic Limb
N/ARecruiting
20 participants
Started: Oct 1, 2021 · Completed: Jun 30, 2024
2 conditions2 sponsors1 location
NCT04798651
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
NARecruiting
150 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT04251377
Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection
NARecruiting
440 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors14 locations
NCT04566497
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
NARecruiting
2,664 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT05009537
Optical Genome Mapping in Hematological Malignancies
N/ARecruiting
200 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
3 conditions1 sponsor4 locations
NCT04986852
Olinvacimab With Pembrolizumab in Patients With mTNBC
PHASE2Recruiting
30 participants
Started: Sep 30, 2021 · Completed: Aug 30, 2026
1 condition2 sponsors1 location
NCT05061732
Helicobacter Pylori Eradication and Follow-up
PHASE4Recruiting
4,447 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03620266
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
NARecruiting
900 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
1 condition9 sponsors8 locations
NCT04851678
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
N/ARecruiting
140 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT04583124
Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)
NARecruiting
56 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05006963
Tele-Rehabilitation in Patients With Temporomandibular Dysfunction
NARecruiting
50 participants
Started: Sep 30, 2021 · Completed: Mar 30, 2027
3 conditions1 sponsor1 location
NCT05019846
SRT Versus SRT+ADT in Prostate Cancer
PHASE3Recruiting
310 participants
Started: Sep 30, 2021 · Completed: Dec 1, 2029
1 condition2 sponsors1 location
NCT05100017
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
NARecruiting
126 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05041907
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
PHASE2Recruiting
3,800 participants
Started: Sep 30, 2021 · Completed: Jan 31, 2027
1 condition1 sponsor7 locations
NCT05419713
Intermediate Visual Space Perception
NARecruiting
180 participants
Started: Sep 30, 2021 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04603807
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases
PHASE3Recruiting
220 participants
Started: Sep 30, 2021 · Completed: Jun 26, 2028
1 condition1 sponsor91 locations
NCT05024383
Dissecting the Heterogeneity of Oral Cancer Pain
NARecruiting
80 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05028933
IMC001 for Clinical Research on Advanced Digestive System Malignancies
PHASE1Recruiting
48 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor2 locations
NCT05073926
Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
N/ARecruiting
100 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05151718
Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
N/ARecruiting
370 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
2 conditions6 sponsors1 location
NCT05243134
The Influence of Anatomic Deformities on the Clinical Efficacy in the Patients With Patellar Dislocation
N/ARecruiting
1,000 participants
Started: Sep 30, 2021 · Completed: Dec 30, 2025
6 conditions1 sponsor1 location
NCT07127393
Adding Chondrus Crispus Seaweeds to a Meal: Effect on Sensory Perception, Physical Comfort, Satiety and Food Intake
NARecruiting
32 participants
Started: Sep 30, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06031792
Radiographic Assessment of the Healing Pattern Associated With Periradicular Endodontic Microsurgery
NARecruiting
44 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT05003843
BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis
NARecruiting
290 participants
Started: Sep 30, 2021 · Completed: Feb 28, 2027
2 conditions1 sponsor42 locations
NCT05077124
Safe and Timely Antithrombotic Removal (STAR) Registry
N/ARecruiting
1,000 participants
Started: Sep 30, 2021 · Completed: Sep 30, 2025
4 conditions1 sponsor30 locations
NCT05029895
A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
N/ARecruiting
170 participants
Started: Sep 29, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor59 locations
NCT04736394
A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients
PHASE3Recruiting
800 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06837766
Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients
N/ARecruiting
40 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05768126
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
PHASE4Recruiting
100 participants
Started: Sep 29, 2021 · Completed: Jan 31, 2026
1 condition4 sponsors1 location
NCT04753879
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
PHASE2Recruiting
38 participants
Started: Sep 29, 2021 · Completed: Dec 1, 2029
1 condition2 sponsors1 location
NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
PHASE1Recruiting
345 participants
Started: Sep 29, 2021 · Completed: Feb 28, 2028
14 conditions1 sponsor17 locations
NCT04278651
Early Antenatal Support for Iron Deficiency Anemia
PHASE4Recruiting
80 participants
Started: Sep 29, 2021 · Completed: Dec 30, 2025
3 conditions2 sponsors1 location
NCT04816227
Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments
N/ARecruiting
180 participants
Started: Sep 29, 2021 · Completed: Oct 30, 2027
1 condition1 sponsor1 location
NCT06308757
Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
NARecruiting
42 participants
Started: Sep 29, 2021 · Completed: Dec 12, 2026
4 conditions1 sponsor1 location
NCT05241106
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
PHASE2Recruiting
15 participants
Started: Sep 29, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05061745
Neuromodulation for Dysphoria
NARecruiting
100 participants
Started: Sep 29, 2021 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT04983875
Mammography and Breast Arterial Calcification: an Information-Sharing Trial
NARecruiting
14,875 participants
Started: Sep 29, 2021 · Completed: Mar 31, 2026
2 conditions2 sponsors1 location
NCT04216342
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
PHASE1Recruiting
64 participants
Started: Sep 29, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04951856
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
PHASE4Recruiting
2,166 participants
Started: Sep 29, 2021 · Completed: Sep 29, 2027
2 conditions3 sponsors1 location
NCT04941274
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
PHASE1/PHASE2Recruiting
86 participants
Started: Sep 29, 2021 · Completed: Jun 1, 2028
1 condition1 sponsor1 location
NCT04940962
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
NARecruiting
45 participants
Started: Sep 29, 2021 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT04895839
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NARecruiting
500 participants
Started: Sep 29, 2021 · Completed: Oct 1, 2025
1 condition1 sponsor7 locations
NCT05133843
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis
NARecruiting
50 participants
Started: Sep 29, 2021 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT04617756
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
PHASE2Recruiting
50 participants
Started: Sep 29, 2021 · Completed: Oct 1, 2026
2 conditions10 sponsors9 locations
NCT04124341
PCS in Severe Treatment Resistant Depression
NARecruiting
15 participants
Started: Sep 29, 2021 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05104645
Analysis of the Psychometric Properties of Kinematic Parameters of Locomotion Measured by Inertial Units. Validation in Healthy Volunteers and Stroke Patients
NARecruiting
60 participants
Started: Sep 29, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05063136
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
PHASE3Recruiting
1,979 participants
Started: Sep 28, 2021 · Completed: Sep 30, 2028
1 condition1 sponsor1 location
NCT05828953
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
PHASE2/PHASE3Recruiting
30 participants
Started: Sep 28, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05147142
Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety
NARecruiting
25 participants
Started: Sep 28, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05020574
Microbiome and Association With Implant Infections
PHASE2Recruiting
200 participants
Started: Sep 28, 2021 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location